Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00653523
What this trial is testing

Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)

Who this might be right for
Hypercholesterolemia
Organon and Co 151
Large-scale testing (Phase 3)Study completedNCT01926782
What this trial is testing

Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 803
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Large-scale testing (Phase 3)Ended earlyNCT00766688
What this trial is testing

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Sanofi 643
Not applicableLooking for participantsNCT07045623
What this trial is testing

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

Who this might be right for
HypertensionDiabetes MellitusDyslipidemia+1 more
Saint Vincent's Hospital, Korea 348
Large-scale testing (Phase 3)Ended earlyNCT00741715
What this trial is testing

Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Sanofi 1,736
Post-approval studies (Phase 4)UnknownNCT00225849
What this trial is testing

Japanese Primary Prevention Project With Aspirin

Who this might be right for
HypertensionHyperlipidemiaDiabetes Mellitus
Ministry of Health, Labour and Welfare, Japan 10,000
Not applicableUnknownNCT02223143
What this trial is testing

A Registration Study for Dyslipidemia

Who this might be right for
Atherosclerotic Vascular Diseases
National Taiwan University Hospital 35,000
Large-scale testing (Phase 3)Study completedNCT00413972
What this trial is testing

Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)

Who this might be right for
Hypercholesterolemia
Organon and Co 392
Large-scale testing (Phase 3)Study completedNCT05255094
What this trial is testing

Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 464
Post-approval studies (Phase 4)Study completedNCT00653835
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Who this might be right for
HypercholesterolaemiaAtherosclerosis
Organon and Co 153
Not applicableLooking for participantsNCT06686615
What this trial is testing

Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2,000
Large-scale testing (Phase 3)Study completedNCT00654095
What this trial is testing

Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

Who this might be right for
Hypercholesterolemia
Organon and Co 146
Not applicableStudy completedNCT03917212
What this trial is testing

Energy Metabolism in Branched-chain Organic Acidemias

Who this might be right for
Energy MetabolismMetabolic SyndromeInsulin Resistance
German Diabetes Center 57
Not applicableUnknownNCT05066932
What this trial is testing

Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia

Who this might be right for
Familial HypercholesterolemiaAtherosclerosis
Assistance Publique - Hôpitaux de Paris 100
Early research (Phase 1)Study completedNCT06225635
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

Who this might be right for
Hyperlipidemias
Shin Poong Pharmaceutical Co. Ltd. 60
Not applicableStudy completedNCT06456658
What this trial is testing

Statin Reminders for Improving Prescribing in Primary Care

Who this might be right for
Cholesterol, ElevatedClinical Decision SupportEducation
Vanderbilt University Medical Center 3,332
Post-approval studies (Phase 4)Study completedNCT00157638
What this trial is testing

Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics

Who this might be right for
DiabetesHypertensionHyperlipidemia+2 more
Hamilton Health Sciences Corporation 1,400
Testing effectiveness (Phase 2)Study completedNCT03216811
What this trial is testing

Nutraceutical in Cardiovascular Primary Prevention

Who this might be right for
Hypercholesterolemia
University Hospital of Ferrara 52
Not applicableStudy completedNCT05129241
What this trial is testing

Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector

Who this might be right for
Primary Hypercholesterolaemia and Mixed DyslipidaemiaAtherosclerotic Cardiovascular Disease
Sanofi 163
Next Page